Search research articles
Contact Us
Filters
Showing results (631-640 of 674) with videos related to
Page
of 68
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2016
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab
F Stephen Hodi, Wen-Jen Hwu, Richard Kefford, et al.
The Journal of Hospital Infection
|
July 5, 2024
Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multi-centre cohort study in six German university hospitals, 2016-2020
N Jazmati, A Mischnik, W V Kern, et al.
Cancer Immunology Research
|
February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trial
Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Plos Medicine
|
January 23, 2025
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study
Raphael S Peter, Alexandra Nieters, Siri Göpel, et al.
Genome Medicine
|
April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
Lijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Journal of Clinical Pharmacology
|
May 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective
Thorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
Thorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2015
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Amita Patnaik, S Peter Kang, Drew Rasco, et al.
Oncotarget
|
March 3, 2012
Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1
Julie S Barber-Rotenberg, Saravana P Selvanathan, Yali Kong, et al.
European Journal of Neurology
|
April 4, 2025
Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?
Johannes Dorst, Jens Dreyhaupt, Deborah Wernecke, et al.
Page
of 68
Search research articles
Search
Showing results (631-640 of 674) with videos related to
Sort By:
Page
of 68
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2016
Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab
F Stephen Hodi, Wen-Jen Hwu, Richard Kefford, et al.
The Journal of Hospital Infection
|
July 5, 2024
Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multi-centre cohort study in six German university hospitals, 2016-2020
N Jazmati, A Mischnik, W V Kern, et al.
Cancer Immunology Research
|
February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trial
Rashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.
Plos Medicine
|
January 23, 2025
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study
Raphael S Peter, Alexandra Nieters, Siri Göpel, et al.
Genome Medicine
|
April 21, 2021
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
Lijin Li, Xiuli Zhang, Xiaoli Wang, et al.
Journal of Clinical Pharmacology
|
May 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective
Thorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2003
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
Thorir D Bjornsson, John T Callaghan, Heidi J Einolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2015
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Amita Patnaik, S Peter Kang, Drew Rasco, et al.
Oncotarget
|
March 3, 2012
Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1
Julie S Barber-Rotenberg, Saravana P Selvanathan, Yali Kong, et al.
European Journal of Neurology
|
April 4, 2025
Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?
Johannes Dorst, Jens Dreyhaupt, Deborah Wernecke, et al.
Page
of 68